Reham Abdelkader | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Reham Abdelkader | Pharmacology | Best Researcher Award 

Head of department | German university in Cairo | Egypt

Dr. Reham Mahmoud Abdel-Kader, Professor of Pharmacology and Toxicology and Chair of the Department at the German University in Cairo, is a distinguished biomedical scientist whose research bridges molecular pharmacology, neurodegenerative diseases, and cancer biology with translational therapeutic innovation. Her scientific contributions focus on elucidating mitochondrial dysfunction, neuroinflammation, and cellular bioenergetics as critical mechanisms in Alzheimer’s disease and oncological disorders, advancing targeted treatment approaches through nanotechnology and pharmacogenomic insights. Dr. Abdel-Kader has established two active research groups investigating Alzheimer’s pathology and mitochondrial roles in breast cancer progression, fostering a strong translational link between bench discovery and therapeutic development. She has published widely in internationally recognized journals in pharmacology, neurobiology, and molecular medicine, and her work has received global recognition through prestigious conference presentations and features in leading scientific outlets. Her research has attracted significant international funding from agencies such as the Swiss National Science Foundation, DAAD-BMBF, and the Science and Technology Development Fund, reflecting the impact and sustainability of her scientific endeavors. A committed academic leader, she has played a vital role in curriculum development, accreditation processes, and capacity-building initiatives that enhance educational quality and research excellence within her institution. Dr. Abdel-Kader actively collaborates with leading scientists and institutions across Europe, including partnerships in Germany and Switzerland, fostering international scientific exchange and innovation. Her patent in nanocomposite synthesis further underscores her commitment to bridging pharmaceutical research and technology-based solutions. Through her scholarly rigor, mentorship, and collaborative leadership, Dr. Abdel-Kader continues to contribute significantly to global pharmacological sciences and to shaping the next generation of health researchers dedicated to advancing human health and societal well-being.

Profiles: Google Scholar | ORCID

Publications

1. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., & others. (2007). Mitochondrial dysfunction: The first domino in brain aging and Alzheimer’s disease? Antioxidants & Redox Signaling,

2. Abdel-Kader, R., Hauptmann, S., Keil, U., Scherping, I., Leuner, K., Eckert, A., & others. (2007). Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacological Research,

3. Eckert, G. P., Renner, K., Eckert, S. H., Eckmann, J., Hagl, S., Abdel-Kader, R. M., & others. (2012). Mitochondrial dysfunction—A pharmacological target in Alzheimer’s disease. Molecular Neurobiology,

4. Franke, C., Nöldner, M., Abdel-Kader, R., Johnson-Anuna, L. N., Wood, W. G., & others. (2007). Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiology of Disease

5. Eckert, G. P., Schiborr, C., Hagl, S., Abdel-Kader, R., Müller, W. E., & Rimbach, G. (2013). Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. Neurochemistry International.

Sulymon Saka | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Sulymon Saka | Infectious Diseases | Best Researcher Award

Resident doctor | Irrua Specialist Teaching Hospital | Nigeria

Dr. Sulýmon Ayobami Saka is an emerging Nigerian physician-scientist whose research bridges clinical medicine, audiology, infectious disease epidemiology, and the integration of artificial intelligence in healthcare. Trained at Ambrose Alli University with first-class honours equivalent in Medicine and Surgery, he has established a distinguished record of multidisciplinary research that spans global health, otolaryngology, and data-driven clinical innovation. His academic contributions include multiple peer-reviewed publications in high-impact journals such as BMC Infectious Diseases, BMC Public Health, and the Journal of Otolaryngology – Head & Neck Surgery, reflecting his commitment to evidence-based advancement in medicine. Dr. Saka’s research experience extends across several international collaborations, including the Bernhard Nocht Institute for Tropical Medicine in Germany and Sleep & Cradle® Solutions in the United States, where he contributes to studies on Lassa fever vaccine development, digital maternal and paediatric health, and long-term sequelae of infectious diseases. His scientific works emphasize the intersection of technology and clinical care—exploring how artificial intelligence, digital health platforms, and precision diagnostics can improve health outcomes in low- and middle-income settings. Recognized with multiple awards, including the ECOWAS Lassa Fever International Conference Scholarship and the Newcastle University Vice-Chancellor’s International Scholarship, Dr. Saka exemplifies a new generation of African medical researchers advancing global scientific dialogue. Through his leadership in research and mentorship, he continues to contribute to projects that not only enhance disease surveillance and clinical epidemiology but also foster equitable access to healthcare innovations. His work underscores a vision for a future where interdisciplinary science, cross-border collaboration, and artificial intelligence converge to transform patient care and strengthen health systems across the developing world. He has 9 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Sibomana, O., Saka, S. A., Grace Uwizeyimana, M., Mwangi Kihunyu, A., Obianke, A., Oluwo Damilare, S., Bueh, L. T., Agbelemoge, B. O. G., & Omoefe Oveh, R. (2025). Artificial Intelligence–Assisted Endoscopy in Diagnosis of Gastrointestinal Tumors: A Review of Systematic Reviews and Meta-Analyses. Gastro Hep Advances.

2. Blackie, F. F., Saka, S. A., Ikhifa, C. E., Okechukwu, E. J., & Agbonifo, M. (2025). Aural Myiasis in a Retroviral-Positive Nigerian Child: A Rare Case of Extensive Ear Infestation. Research Square.

3. Emekolom, O. N., Oladipupo, E. O., Saka, S. A., Ojo, D. O., Edhugo, S. E., Olayinka, A. J., & Aremu-Cole, A. H. (2025). Compliance with Universal Standard Precautions and Perceived Influencing Factors among Nurses in a Tertiary Institution in Edo State, Nigeria. Asian Journal of Research in Nursing and Health.

4. Akhigbe, M. E., Saka, S. A., Ighodaro, O., Ghouse, M. A., Emekolom, O. N., & Okoro, O. V. (2025). Doctors’ Knowledge, Attitudes and Prescription Practices on Antibiotic Use: A Study in a Suburban Tertiary Hospital in Nigeria. BMC Health Services Research.

5. Saka, S. A., Ojo, D. O., Mezu, N. M., Uzuegbu, C. O., Ighodaro, O., Illoh, O. O., Emekolom, O. N., Akpa, O. A., Obiora, E. A., & Muogbo, A. P. (2025). Knowledge, Perception and Preventive Practices of Lassa Fever Among Mothers of Under-Five Children in an Endemic Community in Edo State, Nigeria. Research Square.

Josephat M. Chinawa | Cardiology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Josephat M. Chinawa | Cardiology | Best Researcher Award 

Professor | University of Nigeria | Nigeria

Professor Chinawa Josephat Maduabuchi is a distinguished academic and researcher whose scholarly contributions have significantly advanced the fields of pediatrics, child health, and developmental medicine. With a profound commitment to improving clinical outcomes and advancing evidence-based pediatric care, his research integrates biomedical science, public health, and clinical innovation to address complex challenges affecting child health across global and regional contexts. Professor Chinawa’s academic endeavors span diverse research themes, including congenital anomalies, neurodevelopmental disorders, and pediatric epidemiology, where he has consistently demonstrated excellence through high-impact publications in peer-reviewed international journals. His scholarly output, reflected in numerous publications and substantial citation metrics, underscores his influence within the scientific community and his sustained contribution to medical literature. As a collaborative scientist, he has established strong interdisciplinary and international research partnerships, fostering the exchange of knowledge and advancing translational approaches that bridge the gap between research and clinical application. His leadership in academic institutions and involvement in editorial and professional networks further highlight his role as a mentor and thought leader committed to nurturing the next generation of medical researchers. Through his dedication to pediatric health advancement, Professor Chinawa has not only strengthened academic discourse but also contributed to improving health policies and community well-being, emphasizing equity and access to quality healthcare for children. His professional integrity, research innovation, and societal impact have earned him recognition as a leading figure in pediatric research and as an exemplar of scholarly excellence with a global vision rooted in service to humanity. She has 843 citations from 115 documents with an h-index of 17.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Perception of Rubella Disease and Willingness to Vaccinate Against Rubella Vaccine among Secondary School Adolescents in Enugu, South East Nigeria. (2025). SN Comprehensive Clinical Medicine.

2. Microalbuminuria in Children with Cyanotic Congenital Heart Disease in Enugu, Nigeria: A Comparative Study. (2025). BMC Nephrology.

3. Patent Ductus Arteriosus and Factors Associated with Its Occurrence in Newborns with Perinatal Asphyxia Attending a Teaching Hospital in Southeast Nigeria. (2025). SN Comprehensive Clinical Medicine.

4. Willingness of Secondary School Adolescents to Get Vaccinated Against Malaria: A Cross-Sectional Study in Enugu, South-East Nigeria. (2025). African Health Sciences.

5. Prevalence and Patterns of Neuro-developmental Problems Among Children with Congenital Heart Diseases Attending a Tertiary Institution in South East Nigeria. (2025). Malawi Medical Journal.

Andrea Budnick | Public Health | Best Researcher Award

Published on by Health Scientists

Dr. Andrea Budnick | Public Health | Best Researcher Award 

Senior Researcher | Charité-Universitätsmedizin Berlin | Germany

Dr. Andrea Budnick is a distinguished scholar in Medical Sociology and Rehabilitation Science at Charité – Medical University Berlin, recognized for her pioneering contributions to geriatric care research, social medicine, and caregiving innovations. Her academic journey spans advanced qualifications in medical sociology, medical didactics, and social sciences, culminating in her postdoctoral habilitation and current leadership as a private lecturer and head of a junior research group at Charité. Dr. Budnick’s expertise bridges the domains of aging, homecare, pain management, and social determinants of health, with a particular emphasis on informal caregiving, chronic pain, and the evolving dynamics of long-term care in both national and intercultural contexts. She has led and co-led several high-impact projects funded by national and international agencies, including initiatives on distance caregiving, long COVID care improvement, and transnational collaborations between Germany and Hong Kong addressing the future of homecare. Her extensive publication record in leading international journals reflects a consistent focus on applied, evidence-based interventions that improve the quality of life for older adults and enhance caregiver support systems. Beyond academia, Dr. Budnick has served as an expert consultant for the German Federal Government and the Federal Ministry for Family Affairs, contributing to national policy frameworks on aging, family caregiving, and partnership models in care delivery. Her scholarly impact extends through influential interdisciplinary collaborations that integrate sociological perspectives with clinical and policy-oriented research, fostering a holistic approach to health and social care reform. Internationally respected for her methodological rigor and commitment to bridging science and practice, Dr. Budnick continues to shape contemporary discourse on caregiving innovation, equity in aging, and sustainable healthcare systems through her leadership, mentorship, and research excellence. She has 453 citations from 35 documents with an h-index of 12.

Profiles:  Scopus | ORCID

Publications

1. Koios, D., Kuhnert, R., Dräger, D., Wenzel, A., Kreutz, R., & Budnick, A. (2024). The use of nonpharmacological interventions for chronic pain treatment in community-dwelling older adults with a certified need for care. BMC Geriatrics.

2. Kuhlmey, A., & Budnick, A. (2023). [Informal caregivers in Germany: achieving work-life balance]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

3. Hering, C., Gangnus, A., Budnick, A., Kohl, R., Steinhagen-Thiessen, E., Kuhlmey, A., & Gellert, P. (2022). Psychosocial burden and associated factors among nurses in care homes during the COVID-19 pandemic: Findings from a retrospective survey in Germany. BMC Nursing.

4. Budnick, A., Bünning, F., & Kuhlmey, A. (2022, October). CaRegiving frOm A Distance (ROAD): Home care in the future—flexible and nearby – multimethod qualitative study protocol. BMJ Open.

5. Janson, P., Willeke, K., Zaibert, L., Budnick, A., Berghöfer, A., Kittel-Schneider, S., Heuschmann, P. U., Zapf, A., Wildner, M., Stupp, C., et al. (2022, May 11). Mortality, morbidity and health-related outcomes in informal caregivers compared to non-caregivers: A systematic review. International Journal of Environmental Research and Public Health.

Rastegar Hoseini | Public Health | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Rastegar Hoseini | Public Health | Best Researcher Award 

 Physiology | Razi University | Iran

Dr. Rastegar Hosseini is an accomplished academic and researcher in the field of Sport Physiology, with a specialized focus on Sports Nutrition. Serving as a faculty member at the Faculty of Sport Sciences, Razi University, Kermanshah, he has established a strong reputation for his work at the intersection of nutrition, exercise physiology, and athletic performance. His scholarly contributions reflect a commitment to advancing knowledge in exercise metabolism, dietary strategies, and physiological adaptations to training. Through extensive peer-reviewed publications in internationally indexed journals, Dr. Hosseini has contributed significantly to understanding the complex biochemical and nutritional determinants of performance and recovery in athletes. His research emphasizes the translation of laboratory findings into evidence-based nutritional protocols that enhance performance outcomes, promote metabolic health, and support sustainable athletic development. In addition to his academic output, he has been actively involved in national collaborations with sports federations, wellness centers, and interdisciplinary health networks, where his expertise has informed training methodologies and dietary planning. As a mentor and educator, Dr. Hosseini continues to guide postgraduate research projects that explore innovative nutritional interventions and metabolic adaptations in sport and exercise science. His work embodies a balanced integration of scientific rigor, practical application, and educational leadership, contributing meaningfully to both the academic community and the broader field of applied sports science. Through his collaborations with research groups across Iranian universities and active participation in national health and performance initiatives, he has reinforced the importance of science-driven approaches in optimizing human performance and well-being. Dr. Hosseini’s professional affiliations with leading sport physiology and nutrition societies further underscore his dedication to research excellence, academic integrity, and the advancement of knowledge that benefits both elite athletes and the general population through improved understanding of nutrition and exercise physiology. He has 417 citations from 52 documents with an h-index of 12.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Vitamin D and exercise improve VEGF-B production and IGF-1 levels in diabetic rats: Insights into the role of miR-1 suppression. (2025).

2. The role of the SIRT1 and mTOR pathways in exercise-induced β-cell senescence reduction in type 2 diabetes mellitus. (2025).

3. Kynurenine pathway modulation by exercise in multiple sclerosis: Implications for neuroprotection and inflammation. (2025).

4. Combined effects of sodium alginate supplementation with HIIT and MICT on CCK and PYY levels in men with metabolic syndrome. (2025). 

5. Demographic, cultural, and health correlates of physical activity and sports participation among adults in Kermanshah province, Iran. (2025).

Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Huiling Chen | Oncology | Best Researcher Award

Published on by Health Scientists

Dr. Huiling Chen | Oncology | Best Researcher Award 

Physician | Lanzhou University | China

Dr. Huiling Chen is a distinguished physician and researcher at The Second Hospital and Clinical Medical School, Lanzhou University, recognized for her significant contributions to the field of hematologic malignancies, particularly acute myeloid leukemia (AML). Her research primarily focuses on advancing evidence-based therapeutic strategies through systematic reviews and meta-analyses that inform clinical decision-making and improve patient outcomes. As the lead investigator and corresponding author of a comprehensive meta-analysis published in the Annals of Hematology, Dr. Chen evaluated the efficacy and safety of venetoclax plus azacitidine regimens in relapsed or refractory AML, providing vital insights into their clinical utility and identifying combination chemotherapy as a promising approach for improving remission outcomes. Her expertise lies in clinical epidemiology, biostatistics, and the design and interpretation of complex data in oncology research. Through collaborations with multidisciplinary teams across national and international institutions, she has contributed to multicenter studies that bridge gaps between clinical research and real-world applications. Her scholarly work exemplifies a commitment to scientific rigor, innovation, and translational relevance, with her findings influencing the direction of future clinical trials and treatment paradigms for high-risk AML populations. Dr. Chen’s research efforts aim to optimize therapeutic interventions, enhance personalized treatment planning, and advance precision medicine in hematology. Beyond her academic accomplishments, she upholds a strong dedication to mentoring and fostering collaborative research environments that encourage cross-institutional partnerships and scientific dialogue. Her contributions embody the integration of analytical excellence, clinical insight, and humanitarian vision, underscoring her role as a leader shaping the future of hematologic cancer research and its impact on global health.

Profile: ORCID 

Publications

1. Chen, H., Li, X., Gao, L., Zhang, D., & Han, T. (2022, August). Construction and identification of an immortalized rat intestinal smooth muscle cell line. Neurogastroenterology & Motility.

2. Chen, H., Ren, X., Xu, S., Zhang, D., & Han, T. (2022, July). Optimization of lipid nanoformulations for effective mRNA delivery. International Journal of Nanomedicine.

3. Chen, H., Han, T., Gao, L., & Zhang, D. (2022, January). The involvement of glial cell-derived neurotrophic factor in inflammatory bowel disease. Journal of Interferon & Cytokine Research.

4. Chen, H., Zeng, P., & Zhang, D. (2020, February). Haemophagocytic syndrome triggered by acute lymphoblastic leukaemia with t(9;22)(p24; q11.2). Journal of International Medical Research.

Praveen Kumar Dubey | Health Technology | Best Researcher Award

Published on by Health Scientists

Dr. Praveen Kumar Dubey | Health Technology | Best Researcher Award 

Assistant Professor | Indian Institute of Packaging | India

Dr. Praveen Kumar Dubey is a food science and technology academic whose work spans advanced food processing, functional food development, and innovative biotechnological interventions for nutrition and food sustainability. With formal training in biotechnology, food process engineering, and food science and technology, he has cultivated expertise at the intersection of food engineering, food biotechnology, product innovation, and health-oriented food systems. His academic journey includes service at reputed academic and research institutions, where he has contributed to teaching, laboratory development, and mentoring in food science and nutrition disciplines. Dr. Dubey’s research portfolio encompasses food reformulation for health benefits, valorization of agro-industrial by-products, gluten-free and functional food product development, utilization of pseudocereals and bioactive-rich plant resources, and application of emerging processing technologies for improved physicochemical and nutritional properties. His published scientific works reflect collaborative engagements with national and international researchers addressing critical challenges in food quality, safety, shelf-life enhancement, and value addition to underutilized crops and bioresources. His research outputs appear in internationally recognized journals covering food chemistry, food engineering, food biotechnology, and nutraceutical innovation, contributing to evidence-based advancements in sustainable food systems and consumer-focused health solutions. Dr. Dubey’s professional affiliations include membership in leading scientific societies in food science, reinforcing his commitment to collaborative advancement and knowledge dissemination in the field. Beyond scholarly publications, his academic service includes manuscript evaluation for reputable peer-reviewed journals, highlighting his credibility as an emerging expert in food technology. His work carries significant societal relevance, emphasizing nutrient-dense and inclusive food solutions, waste-to-wealth strategies, and science-based innovations that support public health nutrition, food security, and resource-efficient food processing. Through continuous research, teaching, and professional outreach, Dr. Dubey contributes to the global mission of developing safer, healthier, and more sustainable food systems. He has 95 citations from 16 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Singh, H., Blennow, A., Gupta, A. D., Kaur, P., Dhillon, B., Sodhi, N. S., & Dubey, P. K. (2022). Pulsed light, pulsed electric field and cold plasma modification of starches: Technological advancements & effects on functional properties. Journal of Food Measurement and Characterization.

2. Dubey, P. K., Shukla, R. N., Srivastava, G., Mishra, A. A., & Pandey, A. (2019). Study on quality parameters and storage stability of mango coated with developed nanocomposite edible film. International Journal of Current Microbiology and Applied Sciences.

3. Pandey, A., Mishra, A. A., Shukla, R. N., Dubey, P. K., & Vasant, R. K. (2019). Development of the process for whey based pineapple beverage. International Journal of Current Microbiology and Applied Sciences.

4. Manoharan, S., Dubey, P. K., & Sharma, M. (2024). Recent advances in deep‐fat frying through pretreatments and edible coating to reduce oil absorption. Journal of Food Process Engineering.

5. Dubey, P. K., Kumar, K. S., Rawson, A., Anandakumar, S., Baskaran, N., & Others. (2023). Effect of pulsed electric field on physicochemical properties of rice and black gram fermented batter. Journal of Food Process Engineering.

Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Published on by Health Scientists

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.

Shan Ping Yu | Neuroscience | Lifetime Achievement Award

Published on by Health Scientists

Prof. Dr. Shan Ping Yu | Neuroscience | Lifetime Achievement Award 

Endowed Full Professor | Emory University | United States

Shan Ping Yu is an internationally recognized neuroscientist and Endowed Full Professor at Emory University School of Medicine, known for pioneering research in excitotoxicity, neuroprotection, and neural regeneration. With extensive training spanning premier institutions in China and the United States, he has advanced fundamental understanding of neuronal injury mechanisms, focusing on ionic and molecular pathways involving voltage-gated and ligand-gated channels in apoptotic and necrotic cell death. His laboratory has led groundbreaking innovations including preconditioning strategies to enhance survival and reparative potential of transplanted stem cells, the development of optochemogenetics for precision control of cellular functions, direct reprogramming of glioblastoma cells into neurons as a transformative anti-cancer strategy, and elucidation of inflammatory mechanisms linking early-life pain to neurodevelopmental disturbances. His work has significantly contributed to novel interventions in ischemic stroke, traumatic brain injury, Alzheimer’s disease, and neuropsychiatric-related cognitive deficits. He has secured sustained funding from national research agencies and veterans’ research programs, and contributed as principal investigator or key collaborator on numerous basic, translational, and interventional neuroscience projects. His publication record in leading peer-reviewed journals, high citation impact, and invited presentations at global scientific forums underscore sustained scholarly excellence. He has held leadership roles in national and international committees, including service for major federal funding agencies, advancing scientific priorities and peer-review standards in neurological research. Beyond scientific discovery, he has demonstrated strong commitment to research training and workforce development, mentoring a large cohort of clinical, graduate, and postdoctoral scholars who have progressed to influential roles in academia and biomedicine. His contributions have been recognized through multiple competitive honors and inclusion in media outlets spotlighting high-impact scientific advances. Through integrated basic and translational neuroscience, Shan Ping Yu continues to drive innovations with profound implications for brain repair, neurodegenerative disease treatment, and improved quality of life for patients worldwide. He has 13686 citations from 194 documents with an h-index of 62.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Hu, X., Yu, S. P., Fraser, J. L., Lu, Z., Ogle, M. E., Wang, J. A., & Wei, L. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. The Journal of Thoracic and Cardiovascular Surgery.

2. Yu, S. P., Yeh, C. H., Sensi, S. L., Gwag, B. J., Canzoniero, L. M. T., Farhangrazi, Z. S., et al. (1997). Mediation of neuronal apoptosis by enhancement of outward potassium current. Science.

3. Sensi, S. L., Canzoniero, L. M. T., Yu, S. P., Ying, H. S., Koh, J. Y., Kerchner, G. A., et al. (1997). Measurement of intracellular free zinc in living cortical neurons: Routes of entry. Journal of Neuroscience.

4. Dugan, L. L., Gabrielsen, J. K., Shan, P. Y., Lin, T. S., & Choi, D. W. (1996). Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiology of Disease.

5. Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I. S., Duong, D. M., Seyfried, N. T., et al. (2014). Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nature Medicine,